1-10639058-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001079843.3(CASZ1):āc.5164T>Cā(p.Ser1722Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000831 in 1,083,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001079843.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASZ1 | NM_001079843.3 | c.5164T>C | p.Ser1722Pro | missense_variant | 21/21 | ENST00000377022.8 | NP_001073312.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASZ1 | ENST00000377022.8 | c.5164T>C | p.Ser1722Pro | missense_variant | 21/21 | 1 | NM_001079843.3 | ENSP00000366221.3 |
Frequencies
GnomAD3 genomes AF: 0.0000210 AC: 3AN: 143000Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000638 AC: 6AN: 940132Hom.: 0 Cov.: 32 AF XY: 0.00000891 AC XY: 4AN XY: 449140
GnomAD4 genome AF: 0.0000210 AC: 3AN: 143000Hom.: 0 Cov.: 32 AF XY: 0.0000288 AC XY: 2AN XY: 69456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | The c.5164T>C (p.S1722P) alteration is located in exon 21 (coding exon 18) of the CASZ1 gene. This alteration results from a T to C substitution at nucleotide position 5164, causing the serine (S) at amino acid position 1722 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at